After cluster formation, the prepared libraries were sequenced on an Illumina platform
The dose escalation protocol specifically aims to minimize these effects while building therapeutic levels
From 2019 to 2023, there was a 400% increase in prescriptions and a 500% increase in gross spending
The GLP drugs have now helped to make that a more reasonable goal for many people, especially in patients with type 2 diabetes (T2DM)
What makes stopping realistic is what you built while on the medication: protein intake around one gram per pound of target body weight, resistance training on a regular schedule, and sleep that supports appetite regulation
Clinical trials have demonstrated that slow dose escalation significantly reduces the incidence and severity of these gastrointestinal symptoms, which are the most common reasons for treatment discontinuation